Atherosclerosis: cell biology and lipoproteins-focus on CD40 signaling, PCSK9, and novel animal models.
作者信息
Bürger Christina, Weber Christian, Lutgens Esther, Gerdes Norbert
机构信息
aInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU) bDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany cDepartment of Medical Biochemistry, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Curr Opin Lipidol. 2015 Jun;26(3):245-6. doi: 10.1097/MOL.0000000000000185.
PMID:25950709
Abstract
摘要
相似文献
1
Atherosclerosis: cell biology and lipoproteins-focus on CD40 signaling, PCSK9, and novel animal models.动脉粥样硬化：细胞生物学与脂蛋白——聚焦于CD40信号传导、前蛋白转化酶枯草溶菌素9及新型动物模型
Curr Opin Lipidol. 2015 Jun;26(3):245-6. doi: 10.1097/MOL.0000000000000185.
2
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.针对枯草溶菌素转化酶 9 治疗血脂异常和动脉粥样硬化。
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
3
Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport.脯氨酸内切酶枯草溶菌素/克胰蛋白酶 9 可能影响巨噬细胞内胆固醇摄取和胆固醇逆转运。
FEBS Lett. 2013 May 2;587(9):1271-4. doi: 10.1016/j.febslet.2013.02.027. Epub 2013 Feb 24.
4
Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.通过单腺相关病毒介导的突变型人前蛋白转化酶枯草溶菌素9基因转移诱导持续性高胆固醇血症
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):50-9. doi: 10.1161/ATVBAHA.114.303617. Epub 2014 Oct 23.
5
[Proprotein convertase subtilisin/kexin type 9 (PCSK9) and inhibitors].[前蛋白转化酶枯草溶菌素/kexin 9型（PCSK9）与抑制剂]
Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 2:56-67.
6
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family.PCSK9基因中的新型变体p.Ser465Leu并不能解释一个家族性高胆固醇血症（FH）家族成员中低密度脂蛋白受体（LDLR）活性降低的原因。
Clin Chem Lab Med. 2014 Aug;52(8):e175-8. doi: 10.1515/cclm-2014-0144.
7
PCSK9 and its modulation.PCSK9 及其调控。
Clin Chim Acta. 2015 Feb 2;440:79-86. doi: 10.1016/j.cca.2014.10.044. Epub 2014 Nov 6.
8
Atherosclerosis: cell biology and lipoproteins focus on iNKT cells and CD40/CD40L in atherosclerosis and metabolic disorders.动脉粥样硬化：细胞生物学与脂蛋白，聚焦于动脉粥样硬化和代谢紊乱中的不变自然杀伤T细胞及CD40/CD40L
Curr Opin Lipidol. 2014 Oct;25(5):408-9. doi: 10.1097/MOL.0000000000000120.
9
PCSK9 inhibition in LDL cholesterol reduction: genetics and therapeutic implications of very low plasma lipoprotein levels.PCSK9 抑制剂降低 LDL 胆固醇：极低脂蛋白水平的遗传学和治疗意义。
Pharmacol Ther. 2015 Jan;145:58-66. doi: 10.1016/j.pharmthera.2014.07.004. Epub 2014 Jul 18.
10
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.培养的平滑肌细胞分泌的前蛋白转化酶枯草溶菌素 9（PCSK9）降低巨噬细胞 LDLR 水平。
Atherosclerosis. 2012 Feb;220(2):381-6. doi: 10.1016/j.atherosclerosis.2011.11.026. Epub 2011 Nov 25.
引用本文的文献
1
Mitigating atherosclerosis: Integrating vaccines with gene targets.减轻动脉粥样硬化：将疫苗与基因靶点相结合。
Am Heart J Plus. 2025 Aug 6;57:100588. doi: 10.1016/j.ahjo.2025.100588. eCollection 2025 Sep.
2
Novel Insights in the Metabolic Syndrome-induced Oxidative Stress and Inflammation-mediated Atherosclerosis.代谢综合征诱导的氧化应激和炎症介导的动脉粥样硬化的新见解
Curr Cardiol Rev. 2018 Mar 14;14(1):4-14. doi: 10.2174/1573403X13666171009112250.
Zotero 插件